Very encouraging results on this vaccine so far. The antibody response is better than the best convalescent plasma antibody titers. The vaccine also elicits T cell response that bodes well for durability of protection. But they still need to complete the randomized,
placebo-controlled trial to see if the vaccine actually is both safe and effective (latter is defined as lower number of symptomatic Covid infections in vaccinated vs placebo subjects.